Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01702064
Title Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute|Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.